These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 6430584)

  • 1. Azoreductase activity of Sprague Dawley and Wistar-derived rats towards both carcinogenic and non-carcinogenic analogues of 4-dimethylaminophenylazobenzene (DAB).
    Elliott BM
    Carcinogenesis; 1984 Aug; 5(8):1051-5. PubMed ID: 6430584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The possible role of azoreduction in the bacterial mutagenicity of 4-dimethylaminoazobenzene (DAB) and 2 of its analogues (6BT and 5I).
    Ashby J; Lefevre PA; Callander RD
    Mutat Res; 1983 Mar; 116(3-4):271-9. PubMed ID: 6403852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Azoreduction of dimethylaminoazobenzene (DAB) in primary cultures of rat hepatocytes. Effect of hypolipidemic agents.
    Stoddart AM; Levine WG
    Drug Metab Dispos; 1990; 18(1):36-41. PubMed ID: 1970775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The disposition and in vivo covalent binding to liver DNA of the monoazodyes 6-(p-dimethylaminophenylazo)benzothiazole (6BT) and 5-(p-dimethylaminophenylazo)indazole (5I) after administration to the rat.
    Dashwood RH; Combes RD; Ashby J
    Carcinogenesis; 1986 Jun; 7(6):1029-33. PubMed ID: 3085965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 6-p-Dimethylaminophenylazobenzothiazole: a potent hepatocarcinogen in the rat.
    Elliott BM; Robinson M; Ashby J
    Cancer Lett; 1983 Nov; 21(1):69-76. PubMed ID: 6416666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation between azo reduction and formation in vitro of DNA-bound DAB metabolites in liver microsomes from rats fed on carcinogenic or normal diets.
    Castagna M; Lazar P
    Chem Biol Interact; 1974 Jan; 8(1):61-4. PubMed ID: 4154809
    [No Abstract]   [Full Text] [Related]  

  • 7. Use of an in vivo/in vitro rat liver DNA repair assay to predict the relative rodent hepatocarcinogenic potency of 3 new azo mutagens.
    Beije B; Ashby J
    Carcinogenesis; 1985 Apr; 6(4):611-5. PubMed ID: 3921275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumorigenicity of 3'-hydroxymethyl, 3'-formyl, and 3'-carboxy derivatives of 4-(dimethylamino)azobenzene in rat liver.
    Mori Y; Nagai H; Hori T; Niwa T; Toyoshi K; Koda A; Kawada K; Ojima A
    Gan; 1981 Feb; 72(1):160-5. PubMed ID: 6791985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of the continuous administration of N,N-dimethyl-4-phenylazoaniline (DAB) on the activities and the inducibilities of some drug-metabolizing enzymes in rat liver.
    Autrup H; Thurlow BJ; Warwick GP
    Chem Biol Interact; 1975 Nov; 11(5):313-28. PubMed ID: 148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microsomal azoreduction and glucuronidation in the metabolism of dimethylaminoazobenzene by the rat liver.
    Raza H; Levine WG; Chowdhury NR; Chowdhury JR
    Xenobiotica; 1987 Jun; 17(6):669-77. PubMed ID: 3114967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic gene mutations induced in Big Blue rats by both the potent rat liver azo-carcinogen 6BT and its reported noncarcinogenic analogue 5BT.
    Fletcher K; Soames AR; Tinwell H; Lefevre PA; Ashby J
    Environ Mol Mutagen; 1999; 34(2-3):148-53. PubMed ID: 10529739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutagenicity of the potent rat hepatocarcinogen 6BT to the liver of transgenic (lacI) rats: consideration of a reduced mutation assay protocol.
    Lefevre PA; Tinwell H; Ashby J
    Mutagenesis; 1997 Jan; 12(1):45-7. PubMed ID: 9025097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of azoreduction of dimethylaminoazobenzene by rat liver NADPH-cytochrome P-450 reductase and partially purified cytochrome P-450. Oxygen and carbon monoxide sensitivity and stimulation by FAD and FMN.
    Levine WG; Raza H
    Drug Metab Dispos; 1988; 16(3):441-8. PubMed ID: 2900738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of drugs and hormones on rat liver dimethylaminoazobenzene reductase activity.
    de-Araujo PS; de-Andrade-Silva E; Raw I
    Braz J Med Biol Res; 1982 Apr; 15(1):17-28. PubMed ID: 6217856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carcinogenic activities of hydroxymethyl derivatives of 4-(dimethylamino)azobenzene in the liver of rats, mice, and hamsters.
    Mori Y; Niwa T; Toyoshi K; Nagai H; Koda A; Kawada K; Ojima A; Konishi Y
    Exp Pathol; 1984; 26(1):15-9. PubMed ID: 6090198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Participation of cytochrome P450 in mutagenic activation of the carcinogen 3'-hydroxymethyl-N,N-dimethyl-4-aminoazobenzene and its N-demethylated compounds by rat liver.
    Mori Y; Niwa T; Toyoshi K
    Mutat Res; 1983 Oct; 122(1):13-22. PubMed ID: 6413856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA-binding studies with 6BT and 5I: implications for DNA-binding/carcinogenicity and DNA-binding/mutagenicity correlations.
    Dashwood RH; Combes RD; Ashby J
    Mutat Res; 1988 Mar; 198(1):61-8. PubMed ID: 3127700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of drug-metabolizing activities in the livers of carcinogen-sensitive parent rats and carcinogen-resistant descendants.
    Yoshimoto F; Masuda S; Higashi T; Nishii T; Takamisawa I; Tateishi N; Sakamoto Y
    Cancer Res; 1985 Dec; 45(12 Pt 1):6155-9. PubMed ID: 3933822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Some characteristics of two azoreductase systems in rat liver. Relevance to the activity of 2-[4'-di(2"-bromopropyl)-aminophenylazo]benzoic acid (CB10-252), a compound possessing latent cytotoxic activity.
    Autrup H; Warwick GP
    Chem Biol Interact; 1975 Nov; 11(5):329-42. PubMed ID: 149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uptake and hepatobiliary fate of two hepatocarcinogens, N,N-dimethyl-4-aminoazobenzene and 3'-methyl-N,N-dimethyl-4-aminoazobenzene, in the rat.
    Samuels AR; Bhargava MM; Levine WG
    Cancer Res; 1983 Oct; 43(10):4816-21. PubMed ID: 6411333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.